Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.40 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.39 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.39 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL966475 | 0.81 | SMN1; SMN2 (0.34) | L3MBTL1RAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL11393102 | 0.76 | — | — | |
| Phosphoric Acid SCHEMBL11599912 | 0.75 | SMN1; SMN2 (0.33) | TDP1RAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL10492822 | 0.66 | ATM (0.52) | L3MBTL1ATMTDP1RAB9AALDH1A1 | |
| SCHEMBL166495 | 0.66 | SMN1; SMN2 (0.71) | L3MBTL1ATMTDP1RAB9AALDH1A1 | |
| SCHEMBL10007010 | 0.66 | SMN1; SMN2 (0.71) | L3MBTL1ATMTDP1RAB9AALDH1A1 | |
| SCHEMBL9066312 | 0.66 | ALDH1A1 (0.93) | L3MBTL1ATMTDP1RAB9AALDH1A1 | |
| SCHEMBL314267 | 0.66 | ALDH1A1 (0.93) | L3MBTL1ATMTDP1RAB9AALDH1A1 | |
| SCHEMBL4609604 | 0.65 | POLB (0.57) | L3MBTL1ATMTDP1ALDH1A1HPGD | |
| SCHEMBL259065 | 0.64 | ALDH1A1 (0.80) | L3MBTL1ATMTDP1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2310009-B1 | PARENTERAL AND ORAL FORMULATIONS OF BENZIMIDAZOLES | UNIV HOUSTON (US) | 2017-12-20 | — | — | EP | claimed |
| US-9259390-B2 | Parenteral and oral formulations of benzimidazoles | THE UNIVERSITY OF HOUSTON SYSTEM (US) | 2016-02-16 | — | — | US | claimed |
| US-9259391-B2 | Parenteral and oral formulations of benzimidazoles | THE UNIVERSITY OF HOUSTON SYSTEM (US) | 2016-02-16 | — | — | US | claimed |
| EP-2310009-A2 | PARENTERAL AND ORAL FORMULATIONS OF BENZIMIDAZOLES | UNIVERSITY OF HOUSTON (US) | 2011-04-20 | — | — | EP | claimed |
| US-20100310611-A1 | Parenteral and oral formulations of benzimidazoles | CHOW DIANA SHU-LIAN | 2010-12-09 | — | — | US | claimed |
| WO-2010011289-A2 | PARENTERAL AND ORAL FORMULATIONS OF BENZIMIDAZOLES | UNIVERSITY OF HOUSTON (US) | 2010-01-28 | — | — | WO | claimed |
| US-20090048322-A1 | Parenteral and oral formulations of benzimidazoles | UNIVERSITY OF HOUSTON SYSTEM, THE | 2009-02-19 | — | — | US | claimed |
| US-20080293796-A1 | Parenteral and oral formulations of benzimidazoles | UNIVERSITY OF HOUSTON SYSTEM, THE | 2008-11-27 | — | — | US | claimed |
| US-7423015-B1 | Antihelminthic drugs as a treatment for hyperproliferative diseases | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-09-09 | — | — | US | claimed |
| US-7419996-B2 | Parenteral and oral formulations of benzimidazoles | THE UNIVERSITY OF HOUSTON (US) | 2008-09-02 | — | — | US | claimed |
| WO-2005018623-A2 | PARENTERAL AND ORAL FORMULATIONS OF BENZIMIDAZOLES | THE UNIVERSITY OF HOUSTON (US) | 2005-03-03 | — | — | WO | claimed |
| US-20050038096-A1 | Parenteral and oral formulations of benzimidazoles | THE UNIVERSITY OF HOUSTON | 2005-02-17 | — | — | US | claimed |
| EP-1425012-A1 | ANTIHELMINTHIC DRUGS AS A TREATMENT FOR HYPERPROLIFERATIVE DISEASES | Board of Regents, The University of Texas System (US) | 2004-06-09 | — | — | EP | claimed |
| WO-2002067932-A1 | ANTIHELMINTHIC DRUGS AS A TREATMENT FOR HYPERPROLIFERATIVE DISEASES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-09-06 | — | — | WO | claimed |
| US-20250241898-A1 | Topical Benzimidazole Formulations and Methods for Use in Treating Inflammatory Dermatoses | JJR&D, LLC | 2025-07-31 | — | — | US | disclosed |
| EP-4543441-A2 | TOPICAL BENZIMIDAZOLE FORMULATIONS AND METHODS FOR USE IN TREATING INFLAMMATORY DERMATOSES | JJR&D, LLC (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20240423959-A1 | TOPICAL BENZIMIDAZOLE FORMULATIONS AND METHODS FOR USE IN TREATING INFLAMMATORY DERMATOSES | JJR&D, LLC | 2024-12-26 | — | — | US | disclosed |
| WO-2002067932-A1 | ANTIHELMINTHIC DRUGS AS A TREATMENT FOR HYPERPROLIFERATIVE DISEASES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-09-06 | — | — | WO | disclosed |
| US-5985795-A | CONTAINS INORGANIC METAL ANTIMICROBIAL AGENT, THIAZOLE ANTIMICROBIAL AGENT, HALOALKYLTHIO ANTIMICROBIAL AGENT, IMIDAZOLE ANTIMICROBIAL AGENT, AND UREA ANTIMICROBIAL AGENT | Suganuma, Akio (JP) | 1999-11-16 | — | — | US | disclosed |
| EP-0834253-A2 | Antimicrobial composition | Suganuma, Akio (JP) | 1998-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100310611-A1 | Parenteral and oral formulations of benzimidazoles | SBDS, HBZ, PAICS | L3MBTL1 1368/4885ATM 3306/4885TDP1 4839/4885 |
| US-20050038096-A1 | Parenteral and oral formulations of benzimidazoles | PAICS, SBDS, PBRM1 | L3MBTL1 856/4885ATM 3889/4885TDP1 4371/4885 |
| US-20080293796-A1 | Parenteral and oral formulations of benzimidazoles | SBDS, MRPL38, CYP3A7 | L3MBTL1 1964/4885ATM 3464/4885TDP1 4530/4885 |
| US-20090048322-A1 | Parenteral and oral formulations of benzimidazoles | SBDS, HBZ, PAICS | L3MBTL1 1368/4885ATM 3306/4885TDP1 4839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.